Results 221 to 230 of about 98,010,213 (261)

Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’

Vox Sanguinis, EarlyView.
Ramune Sepetiene, Mohamed Ali, Guillermo Orjuela, Ted Kieffer, Ellen Ollson, Axel Stover, Jason Kang   +6 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Beyond Neutralization: Fc-Dependent Antibody Effector Functions in SARS-CoV-2 Infection

Nature Reviews Immunology, 2023
Michael R D'Agostino, Art Marzok, Matthew S Miller   +2 more
exaly  

Antibody to SARS-CoV-2

Biomedical Safety & Standards, 2021
openaire   +1 more source

Broadly Neutralizing Antibodies to SARS-CoV-2 and Other Human Coronaviruses

Nature Reviews Immunology, 2023
Huanzhang Zhu, Jiang Shibo, Xiaoyu Zhao
exaly  

SARS-CoV-2 Variant Evasion of Monoclonal Antibodies Based on in Vitro Studies

Nature Reviews Microbiology, 2023
David L Robertson, Brian J. Willett, William T Harvey   +2 more
exaly  

IMMUNOASSAY FOR SARS-COV-2 ANTIBODIES

2022
VASHIST SANDEEP KUMAR, GUIFFO DJOKO LIONEL GILLES, GOVIND BHAVESH   +2 more
openaire   +5 more sources

mRNA Vaccine-Elicited Antibodies to SARS-CoV-2 and Circulating Variants

Nature, 2021
Christian Gaebler, Víctor Ramos, Fabian Schmidt   +2 more
exaly  

SARS-CoV-2 RBD Antibodies That Maximize Breadth and Resistance to Escape

Nature, 2021
Martina Beltramello, Dora Pinto, Martin Montiel-Ruiz   +2 more
exaly  

NEUTRALIZING ANTI- SARS-COV-2 ANTIBODIES

2022
NUSSENZWEIG MICHEL, WANG ZIJUN
openaire   +7 more sources

Reduced Sensitivity of SARS-CoV-2 Variant Delta to Antibody Neutralization

Nature, 2021
Etienne Simon-Loriere, Françoise Porrot, Olivier Schwartz   +2 more
exaly